Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NYSE American - Delayed Quote USD

Actinium Pharmaceuticals, Inc. (ATNM)

Compare
1.3900
-0.1300
(-8.55%)
At close: April 3 at 4:00:00 PM EDT
1.4100
+0.02
+(1.44%)
After hours: April 3 at 7:56:24 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
81
1,030
1,144
Operating Expense
42,121
42,121
52,001
35,134
26,108
Operating Income
-42,121
-42,121
-51,920
-34,104
-24,964
Net Non Operating Interest Income Expense
3,878
3,878
3,102
1,087
190
Pretax Income
-38,243
-38,243
-48,818
-33,017
-24,774
Net Income Common Stockholders
-38,243
-38,243
-48,818
-33,017
-24,774
Diluted NI Available to Com Stockholders
-38,243
-38,243
-48,818
-33,017
-24,774
Basic EPS
-1.27
-1.27
-1.83
-1.37
-1.20
Diluted EPS
-1.27
-1.27
-1.83
-1.37
-1.20
Basic Average Shares
30,070.0280
30,070.0280
26,604.0450
24,141.5450
20,568.3730
Diluted Average Shares
30,070.0280
30,070.0280
26,604.0450
24,141.5450
20,568.3730
Total Operating Income as Reported
-42,121
-42,121
-51,920
-34,104
-24,964
Total Expenses
42,121
42,121
52,001
35,134
26,108
Net Income from Continuing & Discontinued Operation
-38,243
-38,243
-48,818
-33,017
-24,774
Normalized Income
-38,243
-38,243
-48,818
-33,017
-24,774
Interest Income
3,878
3,878
3,102
1,087
190
Net Interest Income
3,878
3,878
3,102
1,087
190
EBIT
-42,121
-42,121
-51,920
-34,104
-24,964
EBITDA
-41,310
-41,310
-51,130
-33,405
-24,440
Reconciled Depreciation
811
811
790
699
524
Net Income from Continuing Operation Net Minority Interest
-38,243
-38,243
-48,818
-33,017
-24,774
Normalized EBITDA
-41,310
-41,310
-51,130
-33,405
-24,440
12/31/2021 - 12/27/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNSE Sensei Biotherapeutics, Inc.
0.3253
-11.12%
 
CMMB Chemomab Therapeutics Ltd.
1.0700
-5.31%
 
VERU Veru Inc.
0.5814
-8.41%
 
NKTX Nkarta, Inc.
1.7050
-10.73%
 
RGLS Regulus Therapeutics Inc.
1.8000
-8.16%
 
PSTV Plus Therapeutics, Inc.
0.7749
-12.95%
 
OSRH OSR Holdings, Inc.
2.4700
+68.03%
 
CMPX Compass Therapeutics, Inc.
1.6050
-5.03%
 
DRMA Dermata Therapeutics, Inc.
0.9322
-5.84%
 
CRVO CervoMed Inc.
11.24
-17.23%